Andrea Doria Division of Rheumatology University of Padova Via

CURRICULUM VITAE
PERSONAL INFORMATION
Name
Address
Telephone
Fax
E-mail
Nationality
Date of birth
Andrea Doria
Division of Rheumatology
University of Padova
Via Giustiniani, 2
35128 – Padova – Italy
049/8212202
049/8212191
[email protected]
Italy
29/04/1955
EXPERTISE
•
Principal areas of expertise
He has a long-standing experience in clinical management of connective tissue
disease patients. The Unit in which he works is a 3rd referral rheumatological
Centre, of prominence within Italy, for the diagnosis and management of
patients affected with systemic connective diseases and other rare rheumatic
conditions. In addition, he has expertise in the management and follow-up of
pregnant patients with systemic rheumatic diseases.
Prof. Doria over 200 ISI publications are highly acknowledged. They include
clinical studies describing new manifestations or subgroup of autoimmune
disorders, prognostic risk factors, diagnostic tests and therapeutic interventions
as well as immunochemical studies which evaluate autoantibodies, epitopes
and complementary epitopes of autoantigens. (Impact Factor ISI 2010: 1033)
In addition he has authored or co-authored 3 books, over 90 book chapters or
Conference Proceedings and over 200 abstracts to national and International
Conferences.
WORK EXPERIENCE
• Dates (from – to)
• Name and address of employer
• Type of business or sector
• Occupation or position held
• Main activities and responsibilities
• Dates (from – to)
• Name and address of employer
• Type of business or sector
• Occupation or position held
Page 1 - Curriculum vitae of
LAST_NAME, FIRST_NAME
From 1988 to 1990
Hospital of Belluno, Adria e Rovigo
Outpatient clinic of Rheumatology
Consultant
Taking care of outpatients affected with Rheumatic diseases
FROM 1990 TO 2006
University-Hospital of Padova
Rheumatology
Assistant Professor of Rheumatology, Padova University School of Medicine
Doria, Andtrea
• Main activities and responsibilities
• Dates (from – to)
• Name and address of employer
• Type of business or sector
• Occupation or position held
• Main activities and responsibilities
Taking care of inpatients and outpatients affected with rheumatic disease;
Lecturer at the Postgraduate School of Rheumatology
From 2006 up to now
University-Hospital of Padova
Rheumatology
Associate Professor of Rheumatology, Padova University School of Medicine
Head of the Unit of Connective Tissue Disease and rare Rheumatic Diseases,
He trained and is training many students in Medicine and in Rheumatology
EDUCATION AND TRAINING
• Dates (from – to)
• Name and type of organization
providing education and training
• Principal subjects/occupational
skills covered
• Title of qualification awarded
From 1976 to 1982
Padova University School of Medicine
Medical training
Medical degree
• Level in national classification
(if appropriate)
• Dates (from – to)
• Name and type of organization
providing education and training
• Principal subjects/occupational
skills covered
• Title of qualification awarded
From 1982 to 1986
University of Padova, Postgraduate School of Rheumatology
Residency in Reumatology
Training in Rheumatology
Specialist in Rheumatology
• Level in national classification
(if appropriate)
LANGUAGES
MOTHER TONGUE
Italian
OTHER LANGUAGES
• Reading skills
• Writing skills
• Verbal skills
ADDITIONAL INFORMATION
Page 2 - Curriculum vitae of
LAST_NAME, FIRST_NAME
English
Excellent
Good
Good
He participates on the editorial boards of several Rheumatology and
Immunology journals: Lupus, Autoimmunity, Clinical and Experimental
Rheumatology, Autoimmunity Reviews, Journal of Autoimmunity, Experimental
Biology and Medicine, Rheumatology Reports, Journal Autoimmunity Highlights,
Reumatismo (Official Journal of Italian Society of Rheumatology), Progressi in
Reumatologia (Offical Journal of Italian College of Hospital Rheumatology),
Artrite e Reumatismi.
Doria, Andtrea
ANNEXES
PUBLICATIONS
ISI Pubblications of Prof. Andrea Doria
1.
Gatto M, Zen M, Ghirardello A, Bettio S, Iaccarino L, Punzi L, Doria A. Emerging and
critical issues in the pathogenesis of lupus. Autoimmun Rev. 2012 Sep 18. pii: S15689972(12)00213-3. doi: 10.1016/j.autrev.2012.09.003. [Epubahead of print] PubMed
PMID: 23000207.
2.
Tarricone E, Ghirardello A, Rampudda M, Bassi N, Punzi L, Doria A. Anti-SAE
antibodies in autoimmune myositis: Identification by unlabelled protein
immunoprecipitation in an Italian patient cohort. J Immunol Methods. 2012 Aug 2. [Epub
ahead of print] PubMed PMID: 22884621.
3.
Maestroni S, Di Corato PR, Cumetti D, Chiara DB, Ghidoni S, Prisacaru L, Cantarini L,
Imazio M, Penco S, Pedrotti P, Caforio AL, Doria A, Brucato A. Recurrent pericarditis:
Autoimmune or autoinflammatory? Autoimmun Rev. 2012 Aug 2. [Epub ahead of print]
PubMed PMID: 22884556.
4.
Doria A, Dayer JM, Punzi L. Autoinflammatory diseases: How to put the fire inside the
body out? Autoimmun Rev. 2012 Aug 2. [Epub ahead of print] PubMed PMID:
22884550.
5.
Doria A, Zen M, Bettio S, Gatto M, Bassi N, Nalotto L, Ghirardello A, Iaccarino L, Punzi
L. Autoinflammation and autoimmunity: Bridging the divide. Autoimmun Rev. 2012 Aug
2. [Epub ahead of print] PubMed PMID: 22878274.
6.
Cozzi F, Marson P, Cardarelli S, Favaro M, Tison T, Tonello M, Pigatto E, De Silvestro
G, Punzi L, Doria A. Prognosis of scleroderma renal crisis: a long-term observational
study. Nephrol Dial Transplant. 2012 Aug 1. [Epub ahead of print] PubMed PMID:
22859795.
7.
Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, Boletis J,
Cervera R, Dörner T, Doria A, Ferrario F, Floege J, Houssiau FA, Ioannidis JP, Isenberg
DA, Kallenberg CG, Lightstone L, Marks SD, Martini A, Moroni G, Neumann I, Praga M,
Schneider M, Starra A, Tesar V, Vasconcelos C, van Vollenhoven RF, Zakharova H,
Haubitz M, Gordon C, Jayne D, Boumpas DT. Joint European League Against
Rheumatism and European Renal Association-European Dialysis and Transplant
Association (EULAR/ERA-EDTA) recommendations for the management of adult and
paediatric lupus nephritis. Ann Rheum Dis. 2012 Jul 31. [Epub ahead of print] PubMed
PMID: 22851469.
8.
Visentin M, Salmaso R, Modesti V, Ometto F, Ruffatti A, Punzi L, Doria A. Parotid,
breast, and fascial involvement in a patient who fulfilled the ACR criteria for ChurgStrauss syndrome. Scand J Rheumatol. 2012;41(4):319-21. PubMed PMID: 22804574.
9.
Vidalino L, Doria A, Quarta SM, Crescenzi M, Ruvoletto M, Frezzato F, Trentin L,
Turato C, Parolin MC, Ghirardello A, Iaccarino L, Cavalletto L, Chemello L, Gatta A,
Pontisso P. SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis
C virus-related chronic liver infection. Exp Biol Med (Maywood). 2012 Jul 1;237(7):793802. Epub 2012 Jul 24. PubMed PMID: 22829702.
10.
Zen M, Bassi N, Nalotto L, Canova M, Bettio S, Gatto M, Ghirardello A, Iaccarino L,
Punzi L, Doria A. Disease activity patterns in a monocentric color of SLE patients: a
seven-year follow-up study. Clin Exp Rheumatol. 2012 Jul 5. [Epub ahead of print]
PubMed PMID: 22765883.
Page 3 - Curriculum vitae of
LAST_NAME, FIRST_NAME
Doria, Andtrea
11.
Iaccarino L, Gatto M, Bettio S, Caso F, Rampudda M, Zen M, Ghirardello A, Punzi L,
Doria A. Overlap connective tissue disease syndromes. Autoimmun Rev. 2012 Jun 26.
[Epub ahead of print] PubMed PMID: 22743033.
12.
Manzi S, Sánchez-Guerrero J, Merrill JT, Furie R, Gladman D, Navarra SV, Ginzler EM,
D'Cruz DP, Doria A, Cooper S, Zhong ZJ, Hough D, Freimuth W, Petri MA; on behalf of
the BLISS-52 and BLISS-76 Study Groups. Effects of belimumab, a B lymphocyte
stimulator-specific inhibitor, on disease activity across multiple organ domains in patients
with systemic lupus erythematosus: combined results from two phase III trials. Ann
Rheum Dis. 2012 May 11. [Epub ahead of print] PubMed PMID: 22550315.
13. Doria A, Cutolo M, Ghirardello A, Zen M, Villalta D, Tincani A, Punzi L, Iaccarino L,
Petri M. Effect of pregnancy on serum cytokines in SLE patients. Arthritis Res Ther
2012; 14(2):R66
14. Bartoloni E, Alunno A, Bistoni O, Bizzaro N, Migliorini P, Morozzi G, Doria A, Mathieu
A, Lotzniker M, Allegri F, Riccieri V, Alpini C, Gabrielli A, Tampoia M, Gerli R; On
behalf of the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA)
investigators. Diagnostic value of anti-mutated citrullinated vimentin in comparison to
anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in
rheumatoid arthritis: An Italian multicentric study and review of the literature.
Autoimmun Rev 2012 Feb 27.[Epub ahead of print] PubMed PMID: 22394488
15. Bassi N, Luisetto R, Prete DD, Ghirardello A, Ceol M, Rizzo S, Iaccarino L, Gatto M,
Valente M, Punzi L, Doria A. Induction of the 'ASIA' syndrome in NZB/NZWF1 mice
after injection of complete Freund's adjuvant (CFA). Lupus 2012; 21: 203-9.
16. Taraborelli M, Ramoni V, Brucato A, Airò P, Bajocchi G, Bellisai F, Biasi D, Blagojevic
J, Canti V, Caporali R, Caramaschi P, Chiarolanza I, Codullo V, Cozzi F, Cuomo G,
Cutolo M, De Santis M, De Vita S, Di Poi E, Doria A, Faggioli P, Favaro M, Ferraccioli
G, Ferri C, Foti R, Gerosa A, Gerosa M, Giacuzzo S, Giani L, Giuggioli D, Imazio M,
Iudici M, Iuliano A, Leonardi R, Limonta M, Lojacono A, Lubatti C, Cerinic MM,
Mazzone A, Meroni M, Meroni PL, Mosca M, Motta M, Muscarà M, Nava S, Padovan M,
Pagani G, Paolazzi G, Peccatori S, Ravagnani V, Riccieri V,Rosato E, Rovere-Querini P,
Salsano F, Santaniello A, Scorza R, Tani C, Valentini G, Valesini G, Vanoli M, Vigone B,
Zeni S, Tincani A; on behalf of the IMPRESS investigators.. Successful pregnancies but a
higher risk of preterm births in systemic sclerosis: An Italian multicentric study. Arthritis
Rheum 2011 Dec 28. doi: 10.1002/art.34350. [Epub ahead of print] PubMed PMID:
22213060.
17. Gatto M, Iaccarino L, Canova M, Zen M, Nalotto L, Ramonda R, Punzi L, Doria A.
Pregnancy and vasculitis: A systematic review of the literature. Autoimmun Rev 2011
Dec 3. [Epub ahead of print] PubMed PMID: 22155197.
18. Dooley MA, Jayne D, Ginzler EM, Isenberg D, Olsen NJ, Wofsy D, Eitner F, Appel GB,
Contreras G, Lisk L, Solomons N; ALMS Group (Abud C, Adler S, Alarc G, Albuquerque
E, Almeida F, Alvarellos A, Appel G, Avila H, Menchaca JI, Blume C, Boletis I,
Bonnardeaux A, Braun A, Buyon J, Cervera R, Chen N, Chen S, Contreras G, Da Costa
AG, Davids R, D'Cruz D, De Ramón E, Haya C, Deodhar A, Dooley MA, Doria A,
Dussol B, Emery P, Fiechtner J, Floege J, Fragoso-Loyo H, Furie R, Ghazalli R, Ghossein
C, Gilkeson G, Ginzler E, Grossman J, Gu J, Guillevin L, Hatron PY, Herrera G, Hiepe F,
Houssiau F, Hübscher O, Hura C, Kaplan J, Kirsztajn G, Kiss E, Kutty GA, Laville M,
Lazaro M, Lenz O, Li L, Lightstone L, Lim S, Malaise M, Manzi S, Marcos J, Meyer O,
Bernard C, Monge P, Naicker S, Neal N, Neuwelt M, Neuwelt CM, Nicholls K, Olsen N,
Ordi-Ros J, Ostrov B, Hershey MS, Pestana M, Petri M, Pokorny G, Pourrat J, Qian J,
Radhakrishnan J, Rovin B, Sánchez-Guerrero J, Sanchez Roman J, Shanahan J, Shergy W,
Skopouli F, Spindler A, Striebich C, Sundel R, Swanepoel C, Tan SY, Tate G, Tesaŕ V,
Tikly M, Wang H, Yahya R, Yu X, Zhang F, Zoruba D, Houssay B, Carson P, Snaith M,
Page 4 - Curriculum vitae of
LAST_NAME, FIRST_NAME
Doria, Andtrea
Cattran D). Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis.
N Engl J Med 2011; 365(20):1886-95.
19. Govoni M, Bombardieri S, Bortoluzzi A, Caniatti L, Casu C, Conti F, De Vita S, Doria A,
Farina I, Ferraccioli G, Gremese E, Mansutti E, Mosca M, Padovan M, Piga M, Tincani A,
Tola MR, Tomietto P, Taglietti M, Trotta F, Valesini G, Zen M, Mathieu A; Italian
Society of Rheumatology. Factors and comorbidities associated with first neuropsychiatric
event in systemic lupus erythematosus: does a risk profile exist? A large multicentre
retrospective cross-sectional study on 959 Italian patients. Rheumatology (Oxford) 2012;
51(1):157-68.
20. Doria A, Putterman C, Sarzi-Puttini P, Szekanecz Z, Shoenfeld Y. Controversies in
rheumatism and autoimmunity. Autoimmun Rev 2011 Oct 25. [Epub ahead of print]
PubMed PMID: 22056979.
21. Costenbader KH, Gay S, Riquelme ME, Iaccarino L, Doria A. Genes, epigenetic
regulation and environmental factors: Which is the most relevant in developing
autoimmune diseases? Autoimmun Rev 2011 Oct 25. [Epub ahead of print] PubMed
PMID: 22041580.
22. Rekvig OP, Putterman C, Casu C, Gao HX, Ghirardello A, Mortensen ES, Tincani A,
Doria A. Autoantibodies in lupus: Culprits or passive bystanders? Autoimmun Rev 2011
Oct 25. [Epub ahead of print] PubMed PMID: 22041579.
23. Cervera R, Conti F, Doria A, Iaccarino L, Valesini G. Does sieronegative antiphospholipid
syndrome really exist? Autoimmun Rev 2011 Oct 22. [Epub ahead of print] PubMed
PMID: 22036830.
24. Zeher M, Doria A, Lan J, Aroca G, Jayne D, Boletis I, Hiepe F, Prestele H, Bernhardt P,
Amoura Z. Efficacy and safety of enteric-coated mycophenolate sodium in combination
with two glucocorticoid regimens for the treatment of active lupus nephritis. Lupus 2011;
20:1484-93. Epub 2011 Oct 5. PubMed PMID: 21976398.
25. Bizzaro N, Allegri F, Alpini C, Doria A, Gerli R, Lotzniker M, Mathieu A, Morozzi G,
Bellisai F, Riccieri V, Tampoia M, Migliorini P. Multicentric evaluation of a second
generation assay to detect antiviral citrullinated peptide antibodies: a collaborative study
by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni. J Clin Pathol
2011; 64(12):1139-41.
26. Illei GG, Cervera R, Burt RK, Doria A, Hiepe F, Jayne D, Pavletic S, Martin T, Marmont
A, Saccardi R, Voskuyl AE, Farge D. Current state and future directions of autologous
hematopoietic stem cell transplantation in sistemi lupus erythematosus. Ann Rheum Dis
2011; 70: 2071-4.
27. Musacchio E, Ramonda R, Perissinotto E, Sartori L, Hirsch R, Punzi L, Zambon S, Corti
MC, Baggio G, Manzato E, Doria A, Crepaldi G. The impact of knee and hip
chondrocalcinosis on disability in older people: the ProVA Study from northeastern Italy.
Ann Rheum Dis 2011; 70: 1937-43.
28. Ramonda R, Lo Nigro A, Modesti V, Nalotto L, Musacchio E, Iaccarino L, Punzi L,
Doria A. Atherosclerosis in psoriatic arthritis. Autoimmun Rev 2011; 10: 773-8.
29. Iaccarino L, Ghirardello A, Canova M, Zen M, Bettio S, Nalotto L, Punzi L, Doria A.
Anti-annexins autoantibodies: Their role as biomarkers of autoimmune diseases.
Autoimmun Rev 2011; 10(9): 553-8.
30. Orbach H, Zandman-Goddard G, Boaz M, Agmon-Levin N, Amital H, Szekanecz Z, Szucs G,
Rovensky J, Kiss E, Doria A, Ghirardello A, Gomez-Arbesu J, Stojanovich L, Ingegnoli F, Meroni
PL, Rozman B, Blank M, Shoenfeld Y. Prolactin and Autoimmunity : Hyperprolactinemia Correlates
with Serositis and Anemia in SLE Patients. Clin Rev Allergy Immunol 2011 Feb 3. [Epub ahead of
print] PubMed PMID: 21287295.
31. Ruffatti A, Ross TD, Ciprian M, Bertero MT, Salvatore S, Scarpato S, Montecucco C, Rossi S,
Caramaschi P, Biasi D, Doria A, Rampudda M, Monica N, Fischetti F, Picillo U, Brucato A, Salvan
E, Vittorio P, Meroni P, Tincani A.Antiphospholipid Syndrome Study Group of the Italian Society of
Page 5 - Curriculum vitae of
LAST_NAME, FIRST_NAME
Doria, Andtrea
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
Rheumatology. Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a
prospective multicentre follow-up study. Ann Rheum Dis 2011 Feb 1. [Epub ahead of print]
PubMed PMID: 21285115.
Zen M, Canova M, Campana C, Bettio S, Nalotto L, Rampudda M, Ramonda R, Iaccarino L, Doria
A. The kaleidoscope of glucorticoid effects on immune system. Autoimmun Rev 2011 Jan 8. [Epub
ahead of print] PubMed PMID: 21224015.
Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Cervera R, Doria A, Jayne D, Khamashta
MA, Kuhn A, Gordon C, Petri M, Schneider M, Shoenfeld Y, Smolen JS, Talarico R, Tincani A,
Ward MM, Werth VP, Carmona L. Development of quality indicators to evaluate the monitoring of
SLE patients in routine clinical practice. Autoimmun Rev 2011 Jan 8. [Epub ahead of print]
PubMed PMID: 21224016.
Agmon-Levin N, Blank M, Zandman-Goddard G, Orbach H, Meroni PL, Tincani A, Doria A, Cervera
R, Miesbach W, Stojanovich L, Barak V, Porat-Katz BS, Amital H, Shoenfeld Y. Vitamin D: an
instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression. Ann
Rheum Dis 2011; 70: 145-50.
Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Gorza L, Doria A. Cutting Edge Issues in
Polymyositis. Clin Rev Allergy Immunol 2010 Dec 30. [Epub ahead of print] PubMe
Ostensen M, Brucato A, Carp H, Chambers C, Dolhain RJ, Doria A, Förger F, Gordon C, Hahn S,
Khamashta M, Lockshin MD, Matucci-Cerinic M, Meroni P, Nelson JL, Parke A, Petri M, Raio L,
Ruiz-Irastorza G, Silva CA, Tincani A, Villiger PM, Wunder D, Cutolo M. Pregnancy and
reproduction in autoimmune rheumatic diseases. Rheumatology (Oxford) 2010 Nov 18. [Epub
ahead of print] PubMed PMID: 21097449.
Doria A, Zen M, Canova M, Bettio S, Bassi N, Nalotto L, Rampudda M, Ghirardello A, Iaccarino L.
SLE diagnosis and treatment: When early is early. Autoimmun Rev 2010; 10: 55-60.
Ghirardello A, Rampudda M, Ekholm L, Bassi N, Tarricone E, Zampieri S, Zen M, Vattemi GA,
Lundberg IE, Doria A. Diagnostic performance and validation of autoantibody testing in myositis by
a commercial line blot assay. Rheumatology (Oxford) 2010; 49: 2370-4.
Bertsias GK, Ioannidis JP, Aringer M, Bollen E, Bombardieri S, Bruce IN, Cervera R, Dalakas M,
Doria A, Hanly JG, Huizinga TW, Isenberg D, Kallenberg C, Piette JC, Schneider M, Scolding N,
Smolen J, Stara A, Tassiulas I, Tektonidou M, Tincani A, van Buchem MA, van Vollenhoven R,
Ward M, Gordon C, Boumpas DT. EULAR recommendations for the management of systemic
lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR
standing committee for clinical affairs. Ann Rheum Dis 2010; 69: 2074-82.
Sarzi-Puttini P, Atzeni F, Gerli R, Bartoloni E, Doria A, Barskova T, Matucci-Cerinic M, Sitia S,
Tomasoni L, Turiel M. Cardiac involvement in systemic rheumatic diseases: An update.
Autoimmun Rev 2010; 9: 849-52.
Caforio AL, Brucato A, Doria A, Brambilla G, Angelini A, Ghirardello A, Bottaro S, Tona F, Betterle
C, Daliento L, Thiene G, Iliceto S. Anti-heart and anti-intercalated disk autoantibodies: evidence for
autoimmunity in idiopathic recurrent acute pericarditis. Heart 2010; 96: 779-84.
Bassi N, Ghirardello A, Blank M, Zampieri S, Sarzi-Puttini P, Mantovani A, Shoenfeld Y, Doria A.
IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus. Ann Rheum Dis 2010; 69: 170410.
Amital H, Szekanecz Z, Szücs G, Dankó K, Nagy E, Csépány T, Kiss E, Doria A, Corocher N,
Agmon-Levin N, Orbach H, Zandman-Goddard G, Shoenfeld Y. Serum concentrations of 25-OH
Vitamin D in SLE patients are inversely related to disease activity- is it time to routinely supplement
SLE patients with vitamin D? Ann Rheum Dis 2010; 69: 1155-7.
Vitadello M, Doria A, Tarricone E, Ghirardello A, Gorza L. Myofiber stress-response in myositis:
parallel investigations on patients and experimental animal models of muscle regeneration and
systemic inflammation. Arthritis Res Ther 2010 Mar 24; 12: R52.
Losada I, Sartori L, Di Gianantonio E, Zen M, Clementi M, Doria A. Bisphosphonates in patients
with autoimmune rheumatic diseases: Can they be used in women of childbearing age?
Autoimmun Rev 2010; 9: 547-52.
Page 6 - Curriculum vitae of
LAST_NAME, FIRST_NAME
Doria, Andtrea
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
Zen M, Ghirardello A, Iaccarino L, Tonon M, Campana C, Arienti S, Rampudda M, Canova M, Doria
A. Hormones, immune response, and pregnancy in healthy women and SLE patients. Swiss Med
Wkly 2010; 140(13-14): 187-201.
Pisoni CN, Brucato A, Ruffatti A, Espinosa G, Cervera R, Belmonte M, Sánchez Román J, Montero
Banvidez P, Tincani A, Bertero MT, Doria A, Hughes GRV, Khamashta MA. Failure of Intravenous
Immunoglobulin to prevent Congenital Heart Block. Arthritis Rheum 2010; 62: 1147-52.
Ginzler EM, Wofsy D, Isenberg D, Gordon C, Lisk L, Dooley MA; ALMS Group: Abud C, Adler S,
Alarcón G, Albuquerque E, Almeida F, Alvarellos A, Appel G, Avila H, Blume C, Boletis I,
Bonnardeaux A, Braun A, Buyon J, Cervera R, Chen N, Chen S, Contreras G, Da Costa AG,
Davids R, D'Cruz D, De Ramón E, Deodhar A, Dooley MA, Doria A, Dussol B, Emery P, Fiechtner
J, Floege J, Fragoso-Loyo H, Furie R, Ghazalli R, Ghossein C, Gilkeson G, Ginzler E, Gordon C,
Grossman J, Gu J, Guillevin L, Hatron PY, Herrera G, Hiepe F, Houssiau F, Hübscher O, Hura C,
Kaplan J, Kirsztajn G, Kiss E, Kutty GA, Laville M, Lazaro M, Lenz O, Li L, Lightstone L, Lim S,
Malaise M, Manzi S, Marcos J, Meyer O, Monge P, Naicker S, Neal N, Neuwelt M, Nicholls K,
Olsen N, Ordi-Ros J, Ostrov B, Pestana M, Petri M, Pokorny G, Pourrat J, Qian J, Radhakrishnan J,
Rovin B, Sanchez-Guerrero J, Roman JS, Shanahan J, Shergy W, Skopouli F, Spindler A, Striebich
C, Sundel R, Swanepoel C, Tan SY, Tate G, Tesar V, Tikly M, Wang H, Yahya R, Yu X, Zhang F,
Zoruba D. Nonrenal disease activity following mycophenolate mofetil or intravenous
cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective,
randomized, open-label, parallel-group clinical trial. Arthritis Rheum 2010; 62: 211-21.
Ometto F, Botsios C, Raffeiner B, Sfriso P, Bernardi L, Todesco S, Doria A, Punzi L. Methods used
to assess remission and low disease activity in rheumatoid arthritis. Autoimmun Rev 2010; 9:1614.
Zampieri S, Adami N, Biral D, Ghirardello A, Rampudda ME, Vecchiato M, Savastano S, Corbianco
S, Kern H, Carraro U, Bassetto F, Merigliano S, Doria A. Polymyositis, dermatomyositis and
malignancy: A further intriguing link. Autoimmun Rev 2010; 9: 449-53.
Sfriso P, Ghirardello A, Botsios C, Tonon M, Zen M, Bassi N, Bassetto F, Doria A. Infections and
autoimmunity: the multifaceted relationship. J Leukoc Biol 2010; 87(3): 385-95.
Zampieri S, Doria A, Adami N, Biral D, Vecchiato M, Savastano S, Corbianco S, Carraro U,
Merigliano S. Subclinical myopathy in patients affected with newly diagnosed colorectal cancer at
clinical onset of disease: evidence from skeletal muscle biopsies. Neurol Res. 2010; 32(1): 20-5.
Ghirardello A, Briani C, Lucchetta M, Doria A. Anti-ribosomal P protein antibodies and
neuropsychiatric systemic lupus erythematosus: cross-sectional vs. prospective studies. Lupus
2010; 19: 771-3.
Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Brey R, Cervera R, Doria A, Jayne D,
Khamashta MA, Kuhn A, Gordon C, Petri M, Rekvig OP, Schneider M, Sherer Y, Shoenfeld Y,
Smolen JS, Talarico R, Tincani A, van Vollenhoven RF, Ward MM, Werth VP, Carmona L. EULAR
Recommendations for monitoring systemic lupus erythematosus patients in clinical practice and in
observational studies. Ann Rheum Dis 2010; 69: 1269-74.
Bassetto F, Vindigni V, Scarpa C, Doria A. Breast Prostheses and Connective Tissue Disease
(CTD): Myth or Reality? Anesthetic Plast Surg 2010; 34: 257-63.
Doria A. Atherosclerosis and lupus: what we know and what we should know. J Rheumatol 2009;
36: 2380-2.
Bassi N, Zampieri S, Ghirardello A, Tonon M, Zen M, Beggio S, Matsuura E, Doria A.
oxLDL/beta2GPI complex and anti-oxLDL/beta2GPI in SLE: prevalence and correlates.
Autoimmunity 2009; 42: 289-91.
Appel GB, Contreras G, Dooley MA, Ginzler EM, Isenberg D, Jayne D, Li LS, Mysler E, SánchezGuerrero J, Solomons N, Wofsy D; Aspreva Lupus Management Study Group (Abud C, Adler S,
Alarcón G, Albuquerque E, Almeida F, AlvarellosA, Appel G, Avila H, Blume C, Boletis I,
Bonnardeaux A, Braun A, Buyon J, Cervera R, Chen N, Chen S, Contreras G, Da Costa AG,
Davids R, D'Cruz D, De Ramón E, Deodhar A, Dooley MA, Doria A, Dussol B, Emery P, Fiechtner
J, Floege J, Fragoso-Loyo H, Furie R, Ghazalli R, Ghossein C, Gilkeson G, Ginzler E, Gordon C,
Page 7 - Curriculum vitae of
LAST_NAME, FIRST_NAME
Doria, Andtrea
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
Grossman J, Gu J, Guillevin L, Hatron PY, Herrera G, Hiepe F, Houssiau F, Hübscher O, Hura C,
Kaplan J, Kirsztajn G, Kiss E, Kutty GA, Laville M, Lazaro M, Lenz O, Li L, Lightstone L, Lim S,
Malaise M, Manzi S, Marcos J, Meyer O, Monge P, Naicker S, Neal N, Neuwelt M, Nicholls K,
Olsen N, Ordi-Ros J, Ostrov B, Pestana M, Petri M, Pokorny G, Pourrat J, Qian J, Radhakrishnan J,
Rovin B, Sánchez-Guerrero J, Sanchez Roman J, Shanahan J, Shergy W, Skopouli F, Spindler A,
Striebich C, Sundel R, Swanepoel C, Tan SY, Tate G, Tesaŕ V, Tikly M, Wang H, Yahya R, Yu X,
Zhang F, Zoruba D. Mycophenolate mofetil versus cyclophosphamide for induction treatment of
lupus nephritis. J Am Soc Nephrol. 2009; 20: 1103-12.
Turiel M, Atzeni F, Tomasoni L, de Portu S, Delfino L, Bodini BD, Longhi M, Sitia S, Bianchi M,
Ferrario P, Doria A, Colonna VD, Sarzi-Puttini P. Non-invasive assessment of coronary flow reserve
and ADMA levels: a case-control study of early rheumatoid arthritis patients. Rheumatology
(Oxford) 2009; 48: 834-9.
Ghirardello A, Bendo R, Rampudda ME, Bassi N, Zampieri S, Doria A. Commercial blot assays in
the diagnosis of systemic rheumatic diseases. Autoimmun Rev 2009; 8: 645-9.
Vidalino L, Doria A, Quarta S, Zen M, Gatta A, Pontisso P. SERPINB3, apoptosis and
autoimmunity. Autoimmun Rev 2009; 9: 108-12.
Gordon C, Jayne D, Pusey C, Adu D, Amoura Z, Aringer M, Ballerin J, Cervera R, Calvo-Alén J,
Chizzolini C, Dayer J, Doria A, Ferrario F, Floege J, Guillevin L, Haubitz M, Hiepe F, Houssiau F,
Lesavre P, Lightstone L, Meroni P, Meyer O, Moulin B, O'Reilly K, Praga M, Schulze-Koops H,
Sinico R, Smith K, Tincani A, Vasconcelos C, Hughes G. European consensus statement on the
terminology used in the management of lupus glomerulonephritis. Lupus. 2009;18(3):257-263.
Briani C, Lucchetta M, Ghirardello A, Toffanin E, Zampieri S, Ruggero S, Scarlato M, Quattrini A,
Bassi N, Ermani M, Battistin L, Doria A. Neurolupus is associated with anti-ribosomal P protein
antibodies: An inception cohort study. J Autoimmun 2009; 32: 79-84.
Moroni G, Doria A, Ponticelli C. Cyclosporine (CsA) in lupus nephritis: assessing the evidence.
Nephrol Dial Transplant. 2009; 24(1): 15-20.
Bassi N, Zampieri S, Ghirardello A, Tonon M, Zen M, Cozzi F, Doria A. Pentraxins, Anti-pentraxin
Antibodies, and Atherosclerosis. Clin Rev Allergy Immunol 2009; 37: 36-43.
Ruffatti A, Del Ross T, Ciprian M, Nuzzo M, Rampudda M, Bertero MT, Bergia R, Caramaschi P,
Biasi D, Capsoni F, Montaguti L, Ruffini R, Brucato A, Picillo U, Fanelli V, Riccieri V, Piccoli A,
Valesini G, Doria A, Meroni PL, and Tincani A. Risk factors for a first thrombotic event in
antiphospholipid antibody carriers. A multicenter retrospective follow-up study. Ann Rheum Dis
2009; 68: 397-9.
Imbasciati E, Tincani A, Gregorini G, Doria A, Moroni G, Cabiddu G, Marcelli D. Pregnancy in
women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial
Transplant 2009; 24(2): 519-25.
Imazio M, Brucato A, Doria A, Brambilla G, Ghirardello A, Romito A, Natale G, Palmieri G,
Trinchero R, Adler Y. Antinuclear antibodies in recurrent idiopathic pericarditis: Prevalence and
clinical significance. Int J Cardiol 2009; 136: 289-93.
Doria A, Briani C. Primary prevention of systemic lupus erythematosus. Nat Clin Pract Rheumatol
2008; 4(11): 576-7.
Doria A, Sarzi-Puttini P, Shoenfeld Y. Infections, rheumatism and autoimmunity: the conflicting
relationship between humans and their environment. Autoimmun Rev 2008; 8(1):1-4.
Doria A, Canova M, Tonon M, Zen M, Rampudda E, Bassi N, Atzeni F, Zampieri S, Ghirardello A.
Infections as triggers and complications of systemic lupus erythematosus. Autoimmun Rev 2008;
8(1):24-8.
Doria A, Zampieri S, Sarzi-Puttini P. Exploring the complex relationships between infections and
autoimmunity. Autoimmun Rev 2008; 8(2): 89-91.
Brucato A, Maestroni S, Cumetti D, Thiella G, Alari G, Brambilla G, Imazi M, Doria A, Palmieri G,
Adler Y. Recurrent pericarditis: infectious or autoimmune? Autoimmun Rev 2008; 8: 44-7.
Doria A, Tincani A, Lockshin M. Challenges of lupus pregnancies. Rheumatology (Oxford) 2008;
47: iii9-iii12.
Page 8 - Curriculum vitae of
LAST_NAME, FIRST_NAME
Doria, Andtrea
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.
90.
91.
92.
93.
Doria A, Bajocchi G, Tonon M, Salvarani C. Pre-pregnancy counselling of patients with vasculitis.
Rheumatology (Oxford) 2008; 47: iii13-iii15.
∅stensen M, Lockshin M, Doria A, Valesini G, Meroni P, Gordon C, Brucato A, Tincani A.Update
on safety during pregnancy of biological agents and some immunosuppressive antirheumatic drugs.
Rheumatology (Oxford) 2008; 47: iii28-iii31.
Cooke A, Ferraccioli G, Herrmann M, Romani L, Schulze C, Zampieri S, Doria A. Induction and
protection of autoimmune rheumatic diseases. the role of infections. Clin Exp Rheumatol 2008; 26
(Suppl. 48): S1-S7.
Claesson MH, Nicoletti F, Stosic-Grujicic S, Doria A, Zampieri S. Interactions between infections
and immune-inflammatory cells in type i diabetes mellitus and inflammatory bowel diseases:
evidences from animal models. Clin Exp Rheumatol 2008; 26 (Suppl. 48): S8-S11.
Girschick HJ, Guilherme L, Inman RD, Latsch K, Rihl M, Sherer Y, Shoenfeld Y, Zeidler H, Arienti S,
Doria A. Bacterial triggers and rheumatic diseases. Clin Exp Rheumatol 2008; 26 (Suppl. 48):
S12-S17.
Avcin T, Canova M, Guilpain P, Guillevin L, Kallenberg CGM, Tincani A, Tonon M, Zampieri S,
Doria A. Infections, connective tissue diseases and vasculitis. Clin Exp Rheumatol 2008; 26
(Suppl. 48): S18-S26.
Efthimiou P, Flavell RA, Furlan A, Gasbarrini G, Gava A, Koné-Paut I, Manna R, Punzi L,
Sutterwala FS, Touitou I, Doria A. Autoinflammatory syndromes and infections: pathogenetic and
clinical implications. Clin Exp Rheumatol 2008; 26 (Suppl. 48): S53-S61.
Lalvani A, Meroni PL, Millington KA, Modolo ML, Plebani M, Tincani A, Villalta D, Doria A,
Ghirardello A. Recent advances in diagnostic technology: applications in autoimmune and
infectious diseases. Clin Exp Rheumatol 2008; 26 (Suppl. 48): S62-S66.
Zara G, Ermani M, Rondinone R, Arienti S, Doria A. Thalidomide and sensory neurotoxicity: A
neurophysiological study. J Neurol Neurosur Ps 2008; 79(11): 1258-61. Epub 2008 May 1.
Zampieri S, Biral D, Adami N, Ghirardello A, Rampudda ME, Tonello M, Doria A. Expression of
myositis specific autoantigens during post-natal myogenesis. Neurol Res 2008; 30: 145-8.
Doria A, Briani C. Lupus: improving long-term prognosis. Lupus 2008; 17: 166-70.
Bassi N, Amital D, Amital H, Doria A, Shoenfeld Y. Chronic fatigue syndrome: characteristics and
possible causes for its pathogenesis. Isr Med Assoc J 2008; 10: 79-82.
Shoenfeld Y, Zandman-Goddard G, Stojanovich L, Cutolo M, Amital H, Levy Y, Abu-Shakra M,
Barzilai O, Berkun Y, Blank M, de Carvalho JF, Doria A, Gilburd B, Katz U, Krause I, Langevitz P,
Orbach H, Pordeus V, Ram M, Toubi E, Sherer Y. The mosaic of autoimmunity: hormonal and
environmental factors involved in autoimmune diseases--2008. Isr Med Assoc J 2008; 10: 8-12.
Foti R, Leonardi R, Rondinone R, Di Gangi M, Leonetti C, Canova M, Doria A. Scleroderma-like
disorders. Autoimmun Rev 2008; 7: 331-9.
Doria A, Arienti S, Rampudda M, Canova M, Tonon M, Sarzi-Puttini P. Preventive strategies in
systemic lupus erythematosus. Autoimmun Rev 2008; 7: 192-7.
Atzeni F, Doria A, Ghirardello A, Turiel M, Batticciotto A, Carrabba M, Sarzi-Puttini P. Anti-thyroid
antibodies and thyroid dysfunction in rheumatoid arthritis: prevalence and clinical value.
Autoimmunity 2008; 41: 111-5.
Briani C, Doria A, Ruggero S, Toffanin E, Luca M, Albergoni MP, D'Odorico A, Grassivaro F,
Lucchetta M, De Lazzari F, Balzani I, Battistin L, Vernino S. Antibodies to muscle and ganglionic
acetylcholine receptors (AchR) in celiac disease. Autoimmunity 2008; 41: 100-4.
Atzeni F, Doria A, Ghirardello A, Villalta D, Zampieri S, Carrabba M, Sarzi-Puttini P. Organ-specific
autoantibodies in patients with rheumatoid arthritis treated with adalimumab: a prospective longterm follow-up. Autoimmunity 2008; 41: 87-91.
Sarzi-Puttini P, Atzeni F, Di Franco M, Lama N, Batticciotto A, Iannuccelli C, Dell'Acqua D, de Portu
S, Riccieri V, Carrabba M, Buskila D, Doria A, Valesini G. Anti-polymer antibodies are correlated
with pain and fatigue severity in patients with fibromyalgia syndrome. Autoimmunity 2008; 41: 749.
Page 9 - Curriculum vitae of
LAST_NAME, FIRST_NAME
Doria, Andtrea
94.
95.
96.
97.
98.
99.
100.
101.
102.
103.
104.
105.
106.
107.
108.
109.
Sarzi-Puttini P, Doria A. Organ specific-autoantibodies: their role as markers and predictors of
disease. Autoimmunity 2008; 41: 1-10.
Sarzi-Puttini P, Buskila D, Carabba M, Doria A, Atzeni F. Treatment strategy in Fibromyalgia
syndrome: where are we now? Semin Arthritis Rheum 2008; 37(6): 353-65.
Bassi N, Ghirardello A, Iaccarino L, Zampieri S, Rampudda ME, Atzeni F, Sarzi-Puttini P, Shoenfeld
Y, Doria A. OxLDL/β2GPI-anti-oxLDL/β2GPI complex and atherosclerosis in SLE patients.
Autoimmunity Rev 2007; 7: 52-8.
Iaccarino L, Arienti S, Rampudda M, Canova M, Atzeni F, Sarzi Puttini P, Doria A. Mycophenolate
mofetil in lupus glomerulonephritis: effectiveness and tolerability. Ann N Y Acad Sci 2007;
1110:516-24.
Shoenfeld Y, Szyper-Kravitz M, Witte T, Doria A, Tsutsumi A, Tatsuya A, Dayer JM, Roux-Lombard
P, Fontao L, Kallenberg CG, Bijl M, Matthias T, Fraser A, Zandman-Goddard G, Blank M, Gilburd
B, Meroni PL. Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid
P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus.
Ann N Y Acad Sci 2007;1108: 227-39.
Atzeni F, Doria A, Sarzi-Puttini P. What is the role of rituximab in the treatment of rheumatoid
arthritis? Autoimm Rev 2007; 6(8): 553-8.
Atzeni F, Doria A, Carrabba M, Turiel M, Sarzi-Puttini P. Potential terget of Infliximab in
autoimmune and inflammatory diseases. Autoimm Rev 2007; 6: 529-36.
Zampieri S, Ghirardello A, Rossini K, Iaccarino L, Bassi N, Atzeni F, Sarzi-Puttini P, Doria A.
Antigen preparation for immunological studies in systemic autoimmune diseases. Ann N J Acad
Sci 2007; 1109: 193-202.
Ghirardello A, Villalta D, Morozzi G, Afeltra A, Galeazzi M, Gerli R, Mathieu A, Meroni P, Migliorini
P, Radica A, Ricceri V, Ruffatti A, Sebastiani GD, Tincani A, Doria A, on Behalf of FIRMA Group.
Evaluation of current methods for the m easurement of serum anti-double-stranded DNA
antibodies. Ann N J Acad Sci 2007; 1109: 401-406.
Ghirardello A, Bizzaro N, Zampieri S, Iaccarino L, Bassi N, Tozzoli R, Ruffatti A, Villalta D, Tonutti
E, Doria A. Biological and clinical relevance of anti-prothrombin antibodies. Ann N Y Acad Sci
2007;1109:503-10.
Orbach H, Zandman-Goddard G, Amital H, Barak V, Szekanecz Z, Szucs G, Danko K, Nagy E,
Csepany T, Carvalho JF, Doria A, Shoenfeld Y. Novel Biomarkers in Autoimmune Diseases:
Prolactin, Ferritin, Vitamin D, and TPA Levels in Autoimmune Diseases. Ann N Y Acad Sci. 2007;
1109:385-400.
Bizzarro N, Ghirardello A, Zampieri S, Iaccarino L, Tozzoli R, Ruffatti A, Villalta D, Doria A. Antiprothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15-year
longitudinal study. J Thromb Haemost 2007 5: 1158-64.
Mosca M, Strigini F, Doria A, Iaccarino L, Pratesi F, Tani C, Zampieri S, D Chimenti, Ghirardello A,
Carmignani A, Cecchi M, Migliorini P, Bombardieri S. Anti-C1q antibodies in pregnant patients with
systemic lupus erythematosus. Clin Exp Rheumatol 2007; 25: 449-52.
Gerosa M, Cimaz R, Stramba-Badiale M, Goulene K, Meregalli E, Trespidi L, Acaia B, Tincani A,
Danieli E, Motta M, Doria A, Zulian F, Brucato A, Riboldi P, Meroni PL. Electrocardiographic
abnormalities in infants born from mothers with autoimmune diseases: a multicenter prospective
study. Rheumatology 2007; 46: 1285-9.
Iaccarino L, Rampudda ME, Canova M, Della Libera S, Sarzi-Puttini P; Doria A. Mycophenolate
mofetil: what is its place in the treatment of autoimmune rheumatic diseases? Autoimmunity Rev
2007; 6: 190-5.
Moroni G, Doria A, Mosca M, Alberighi OD, Ferraccioli G, Todesco S, Manno C, Altieri P, Ferrara R,
Greco S, Ponticelli C. A Randomized Pilot Trial Comparing Cyclosporine and Azathioprine for
Maintenance Therapy in Diffuse Lupus Nephritis over Four Years. Clin J Am Soc Nephrol 2006;
1: 925-32.
Page 10 - Curriculum vitae of
LAST_NAME, FIRST_NAME
Doria, Andtrea
110. Hengstman GJD, ter Laak HJ, Vree Egberts WTM, Lundberg IE, Moutsopoulos HM, Vencovsky J,
Doria A, Mosca M, van Venrooij WJ, van Engelen BGM. Anti-SRP autoantibodies, marker of a
necrotizing myopathy. Ann Rheum Dis 2006; 65: 1635-1638.
111. Doria A, Iaccarino L, Arienti S, Rampudda ME, Canova MG, Rondinone R, Todesco S.
Mycophenolate mofetil and systemic lupus erythematosus. Lupus 2006; 15 Supplement: 44-54.
112. Shoenfeld Y, Howard JA. Carp HJA, Molina V, Blank M, Cervera R, Tincani A, Faden D, Lojacono A,
Doria A, Konova E, Meroni PL. Autoantibodies and Prediction of Reproductive Failure. Am J
Reprod Immunol 2006; 337-44.
113. Briani C, Doria A, Marcolongo R, Tognon S, Ruggero S, Toffanin E, Ermani M Ghirardello A,
Zampieri S, Semenzato G. Increased titres of IgM anti-heparan sulfate antibody in Behçet’s
Disease. Clin Exp Rheumatol 2006; 24(5 Suppl 42): S104-7.
114. Tincani A, Danieli E, Nuzzo M, Scarsi M, Motta M, Cimaz R, Lojacono A, Nacinovich R, Taddei F,
Doria A, Brucato A, Meroni PL and for the Pregnancy Study Group of Italian Society of
Rheumatology. Impact of in utero environment on the offspring of lupus patients. Lupus 2006; 15:
801-7.
115. Doria A, Sfriso P. Adalimumab in Psoriatic Arthritis. Drugs 2006; 66: 1497-99.
116. Østensen M, Khamashta M, Lockshin M, Parke A, Brucato A, Carp H, Doria A, Rai R, Meroni PL,
Cetin I, Derksen R, Branch W, Motta M, Gordon C, Ruiz-Irastorza G, Spinillo A, Friedman D, Cimaz
R, Czeizel A, Piette JC, Cervera R, Levy R, Clementi M, De Carolis S, Petri M, Shoenfeld Y, Faden
D, Valesini G, Tincani A. Anti-inflammatory and immunosuppressive drugs and reproduction.
Arthritis Res Ther 2006; 8 (3): 209.
117. Doria A, Iaccarino L, Ghirardello A, Zampieri S, Arienti S, Sarzi-Puttini P, Atzeni F, Piccoli A, Todesco
S. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 2006;
119: 1497-1499.
118. Doria A, Iaccarino L, Arienti S, Ghirardello A, Zampieri S, Rampudda ME, Cutolo M, Tincani A,
Todesco S. Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic
diseases. Reprod Toxicol 2006; 22(2): 234-241
119. Sarzi-Puttini P, Atzeni F, Diana A, Doria A, Furlan R. Increased Neural Sympathetic Activation in
Fibromyalgia syndrome. Ann NY Acad Sci 2006; 1069: 109-17.
120. Doria A, Iaccarino L, Sarzi-Puttini P, Ghirardello A, Zampieri S, Arienti S, Cutolo M, Todesco S.
Estrogens in Pregnancy and systemic lupus erythematosus. Ann NY Acad Sci 2006; 1069: 24756.
121. Tarricone E, Ghirardello A, Zampieri S, Rampudda ME, Doria A, Gorza L. Cell stress-response in
skeletal muscle myofibers. Ann NY Acad Sci 2006; 1069: 472-6.
122. Briani C, Doria A, Sarzi-Puttini P, Dalakas MC. Update on idiopathic inflammatory myopathies.
Autoimmunity. 2006; 39: 161-70.
123. Zampieri S, Ghirardello A, Iaccarino L, Briani C, Sarzi-Puttini P, Atzeni F, Arienti S, Todesco S,
Doria A. Polymyositis-dermatomyositis and infections. Autoimmunity 2006; 39: 191-6.
124. Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Bendo R, Briani C, Rondinone R, Sarzi-Puttini
P, Todesco S, Doria A. Clinical implications of autoantibody screening in patients with autoimmune
myositis. Autoimmunity 2006; 39(3): 217-21.
125. Doria A, Iaccarino L, Ghirardello A, Arienti S, Zampieri S, Rampudda ME, Tincani A, Todesco S.
Seltene autoimmune rheumatische erkrankungen in der schwangerschaft: systemische sklerose,
dermato-polymyositis und vaskulitiden. Z Rheumatol 2006; 65: 200-208.
126. Brucato A, Brambilla G, Moreo A, Alberti A, Munforti C, Ghirardello G, Doria A, Shinar Y, Livneh A,
Adler Y, Shoenfeld Y, Palmieri G, Spodick DH. Long term outcomes in difficult to treat recurrent
pericarditis. Am J Cardiol 2006; 98(2): 267-271.
127. Rinaldi S, Ghisi M, Iaccarino L, Zampieri S, Ghirardello A, Sarzi-Puttini P, Perini G, Todesco S,
Sanavio E, Doria A. Influence of coping skills on health-related quality of life in SLE patients.
Arthritis Rheum 2006; 55: 427-33.
128. Tincani A, Bompane D, Danieli E, Doria A. Pregnancy, lupus and antiphosphpolipid syndrome
(Huges syndrome). Lupus 2006; 15: 156-60.
Page 11 - Curriculum vitae of
LAST_NAME, FIRST_NAME
Doria, Andtrea
129. Drosera M, Facchetti F, Landolfo S, Mondini M, Nyberg F, Parodi A, Santoro A, Zampieri S, Doria
A. Role of soluble and cell surface molecules in the pathogenesis of autoimmune skin disease. Clin
Exp Rheumatol 2006; 24: S7-S13.
130. Bano S, Bombardieri S, Doria A, Iaccarino L, Lehmann P, Mosca M, Rondinone R, Sontheimer RD,
Kuhn A. Lupus erythematosus and the skin. Clin Exp Rheumatol 2006; 24: S26-S35.
131. Asherson RA, Francès C, Iaccarino L, Khamashta MA, Malacarne F, Piette JC, Tincani A, Doria A.
The antiphospholipid antibody syndrome: diagnosis, skin manifestations and current therapy. Clin
Exp Rheumatol 2006; 24: S46-S51.
132. Griffiths CEM, Iaccarino L, Naldi L, Olivieri I, Pipitone N, Salvarani C, Doria A. Psoriasis and
psoriatic arthritis: immunological aspects and therapeutic guidelines. Clin Exp Rheumatol 2006;
24: S72-S78.
133. Galeazzi M, Gasbarrini G, Ghirardello A, Grandemange S, Hoffman HM, Manna R, Podswiadek M,
Punzi L, Sebastiani GD, Touitou I, Doria A. Autoinflammatory syndromes. Clin Exp Rheumatol
2006; 24: S79-S85.
134. Hengstman GJD, Vree Egberts WTM, Seelig HP, Lundberg IE, Moutsopoulos HM, Doria A, Mosca
M, Vencovsky J, van Venrooij WJ, van Engelen BGM. Clinical characteristics of patients with
myositis and autoantibodies to different fragments of the Mi-2β antigen. Ann Rheum Dis 2006; 65:
242-5.
135. Karassa FB., Afeltra A, Ambrozic A, Chang D-M, De Keyser F, Doria A, Galeazzi M, Hirohata S,
Hoffman IEA, Inanc M, Massardo L, Mathieu A, Mok CC, Morozzi G, Sanna G, Spindler AJ,
Tzioufas AG, Yoshio T, Ioannidis JPA. Accuracy of Anti-Ribosomal P Protein Antibody Testing for
Diagnosis of Neuropsychiatric Systemic Lupus Erythematosus: An International Meta-Analysis.
Arthritis Rheum 2006; 54: 312-24.
136. Doria A, Sarzi-Puttini P, Shoenfeld Y. 2nd Conference on Heart, Rheumatism and Autoimmunity,
Pescara, Italy. May 19 – 20, 2005. Autoimmunity Rev 2006; 5(1):55-63.
137. Zampieri S, Alaibac M, Iaccarino L, Rondinone R, Ghirardello A, Sarzi-Puttini P, Peserico A, Doria
A. TNF-{alpha} is expressed in refractory skin lesions from subacute cutaneous lupus
erythematosus patients. Ann Rheum Dis 2006; 65(4): 545-8.
138. Shoenfeld Y, Gerli R, Doria A, Matsuura E, Matucci Cerinic M, Ronda N, Jara LJ, Abu-Shakra M,
Meroni PL, Sherer Y. Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases.
Circulation 2005; 112: 3337-47.
139. Sarzi-Puttini P, Atzeni F, Iaccarino L, Doria A. Environment and systemic lupus erythematosus: an
overview. Autoimmunity 2005: 38: 465-72.
140. Sarzi-Puttini P, Atzeni F, Capsoni F, Lubrano E, Doria A. Drug-induced lupus erythematosus.
Autoimmunity 2005: 38: 507-18.
141. Briani C, Zara G, Rondinone R, Iaccarino L, Ruggero S, Toffanin E, Ermani M, Ghirardello A,
Zampieri S, Sarzi-Puttini P, Doria A. Positive and negative effects of thalidomide on refractory
cutaneous lupus erythematosus. Autoimmunity 2005: 38: 549-55.
142. Tincani A, Rebaioli CB, Frassi M, Taglietti M, Gorla R, Cavazzana I, Faden D, Taddei F, Lojacono
A, Motta M, Trepidi L, Meroni P, Cimaz R, Ghirardello A, Doria A, Pisoni MP, Muscara M, Brucato
A; Pregnancy Study Group of Italian Society of Rheumatology. Pregnancy and autoimmunity:
maternal treatment and maternal disease influence on pregnancy outcome. Autoimmun Rev.
2005; 4(7): 423-8.
143. Doria A, Sarzi-Puttini P. Heart, rheumatism and autoimmunity: an old intriguing link. Lupus 2005;
14 (9): 643-6.
144. Brucato A, Shinar Y, Brambilla G, Robbiolo L, Ferrioli G, Patrosso MC, Zanni D, Penco S, Boiani E,
Ghirardello A, Caforio ALP, Bergantin A, Tombini V, Moreo A, Ashtamkar L, Doria A, Shoenfeld Y,
Livneh A. Idiopathic recurrent acute pericarditis: Familial Mediterranean Fever mutations and
disease evolution in a large cohort of Caucasian patients. Lupus 2005; 14 (9): 670-4.
145. Doria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turriel M, Petri M. Cardiac involvement in systemic
lupus erythematosus. Lupus 2005; 14 (9): 683-6.
Page 12 - Curriculum vitae of
LAST_NAME, FIRST_NAME
Doria, Andtrea
146. Atzeni F, Sarzi-Puttini P, Doria A, Boiardi L, Pipitone N, Salvarani C. Behçet’s disease and
cardiovascular involvement. Lupus 2005; 14 (9): 723-6.
147. Turiel M, Peretti R, Sarzi-Puttini P, Atzeni F, Doria A. Cardiac imaging techniques in systemic
autoimmune diseases. Lupus 2005; 14 (9): 727-31.
148. Sarzi-Puttini P, Atzeni F, Turiel M, Iaccarino L, Doria A. Tumor necrosis factor-α, biological agents
and cardiovascular risk. Lupus 2005; 14 (9): 780-4.
149. Zandman-Goddard G, Blank M, Langevitz P, Slutsky L, Pras M, Levy Y, Shovman O, Witte T, Doria
A, Rovensky J, Shoenfeld Y. Anti-serum amyloid component P (SAP) antibodies in SLE patients
correlate with disease activity. Ann Rheum Dis 2005; 64: 1698-1702.
150. Turiel M, Sarzi-Puttini P, Peretti R, Rossi E, Atzeni F, Parsons W, Doria A. Thrombotic risk factors
in primary antiphospholipid syndrome: a five-year prospective study. Stroke 2005; 36(7): 1490-4.
151. Turiel M, Sarzi-Puttini P, Peretti R, Ionizzato S, Muzzupappa S, Atzeni F, Rossi E, Doria A. Fiveyear follow-up by transesophageal echocardiographic studies in primary antiphospholipid
syndrome. Am J Cardiol 2005; 96(4): 574-9.
152. Zampieri S, Iaccarino L, Ghirardello A, Tarricone E, Arienti S, Sarzi-Puttini Piercarlo, Gambari PF,
Doria A. Systemic lupus erythematosus, atherosclerosis, and autoimmunity. Ann NY Acad Sci
2005; 1051:351-61.
153. Atzeni F, Turiel M, Capsoni F, Doria A, Meroni PL; Sarzi-Puttini P. Autoimmunity anti-TNFα agents.
Ann NY Acad Sci 2005; 1051:559-69.
154. Villalta D, Tozzoli R, Bizzaro N, Tonutti E, Ghirardello A, Doria A. The relevance of autoantigen
source and cutoff definition in antichromatin (nucleosome) antibody immunoassays. Ann N Y Acad
Sci 2005 Jun;1050:176-84.
155. Doria A, Sherer Y, Meroni PL, Shoenfeld Y. Inflammation and accelerated atherosclerosis – Basic
mechanisms. Rheum Dis Clin N Am 2005; 31: 329-54.
156. Doria A, Mosca M, Gambari PF, Bombardieri S. Defining unclassifiable connective tissue diseases:
incomplete, undifferentiated or both? J Rheumatol 2005; 32: 213-5.
157. Kuhn A, Rondinone R, Doria A, Shoenfeld Y. 1st International Conference on Cutaneous Lupus
Erythematosus. Düsseldorf, Germany, September 1-4, 2004. Autoimmunity Rev 2005: 4: 66-78.
158. Capsoni F, Sarzi-Puttini P, Atzeni F, Minonzio F, Bonara P, Doria A, Carrabba M. Effect of
adalimumab on neutrophil function in patients with rheumatoid arthritis. Arthritis Res Ther 2005; 7:
R250-R255.
159. Zampieri S, Ghirardello A, Iaccarino L, Tarricone E, Gambari PF, Doria A. Anti-JO-1 antibodies.
Autoimmunity 2005; 38: 73-78.
160. Ghirardello A, Zampieri S, Iaccarino L, Tarricone E, Gambari PF, Doria A. Anti-MI-2 antibodies.
Autoimmunity 2005; 38: 79-83.
161. Atzeni F, Sarzi-Puttini P, Doria A, Iaccarino L, Capsoni F. Potential off-label use of infliximab in
autoimmune and non-autoimmune diseases: a review. Autoimmunity Rev 2005; 4(3):144-52.
162. Ghirardello A, Doria A, Zampieri S, Tarricone E, Tozzoli R, Villalta D, Bizzaro N, Piccoli A, Gambari
PF. Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patients. J
Autoimmunity 2004; 22: 235-40.
163. Doria A, Shoenfeld Y, Pauletto P. Premature coronary disease in systemic lupus. N Eng J Med
2004; 350(15):1571-5.
164. Marai I, Shoenfeld Y, Bizzaro N, Villalta D, Doria A, Tonutti E, Tozzoli R. IgA and IgG tissue
transglutaminase antibodies in systemic lupus erythematosus. Lupus 2004; 13(4): 241-4.
165. Briani C, Zara G, Rondinone R, Della Libera S, Ermani M, Ruggero S, Ghirardello A, Zampieri S,
Doria A. Thalidomide neurotoxicity: prospective study in patients with lupus erythematosus.
Neurology 2004: 62: 2288-90.
166. Doria A, Sarzi Puttini PC, Shoenfeld Y. Heart Rheumatism and Autoimmunity. Milan, Italy. February
5-7, 2004. Autoimmunity Rev 2004; 3 (4): 337-354.
167. Doria A, Iaccarino L, Ghirardello A, Briani C, Zampieri S, Tarricone E, Gambari PF. Pregnancy in
rare autoimmune rheumatic diseases: UCTD, MCTD, myositis, systemic vasculitis, and Beçhet
disease. Lupus 2004; 13 (9): 690-5.
Page 13 - Curriculum vitae of
LAST_NAME, FIRST_NAME
Doria, Andtrea
168. Rinaldi S, Doria A, Salaffi F, Ermani M, Iaccarino L, Ghirardello A, Zampieri S, Gambari PF, Perini
G. Health-related quality of life in Italian patients with systemic lupus erythematosus. I. Relationship
between physical and mental dimension and impact of age. Rheumatology 2004; 43: 1574-9.
169. Doria A, Rinaldi S, Ermani M, Salaffi F, Iaccarino L, Ghirardello A, Zampieri S, Della Libera S, Perini
G, Todesco S. Health-related quality of life in Italian patients with systemic lupus erythematosus. II.
Role of clinical, immunological, and psychological determinants. Rheumatology 2004; 43: 1580-6.
170. Doria A, Ghirardello A, Iaccarino L, Zampieri S, Punzi L, Tarricone E, Ruffatti A, Sulli A, Sarzi Puttini
PC, Gambari PF, Cutolo M. Pregnancy, cytokines and disease activity in systemic lupus
erythematosus. Arthritis Rheum 2004; 51: 989-995.
171. Villata D, Romelli PB, Savina C, Bizzarro N, Bozzoli R, Tonutti E, Ghirardello A, Doria A. AntidsDNA antibody avidità determination by simple reliable ELISA method for SLE diagnosis and
monitorino. Lupus 2003; 12: 31-36.
172. Zampieri S, Mahler M, Blüthner M, Qiu Z, Malmegrim K, Ghirardello A, Doria A, van Venrooij WJ,
Raats JMH. Recombinant anti-P proteins autoantibodies isolated from a human autoimmune
library: reactivity, specificity and epitope recognition. Cell Mol Life Sci 2003; 60: 588-98.
173. Doria A, Shoenfeld Y, Wu R, Gambari PF, Puato M, Ghirardello A, Gilburd B, Corbanese S, Patnaik
M, Zampieri S, Peter JB, Favaretto E, Iaccarino L, Sherer Y, Todesco S, Pauletto P. Risk factors for
subclinical atherosclerosis in a prospective cohort of patients with Systemic Lupus Erythematosus.
Ann Rheum Dis 2003, 62: 1071-77.
174. Bizzaro N, Villalta D, Tonutti E, Doria A, Tampoia M, Bassetti D, Tozzoli R. IgA AND IgG tissue
transglutaminase antibody prevalence and clinical significance in connective tissue diseases,
inflammatory bowel disease, and primary biliary cirrhosis. Digest Dis Sci 2003; 48: 2360-5.
175. Righi A, Schiavon F, Jablonska S, Doria A, Blasczyk M, Rondinone R, Todesco S. Intravenous
immunoglobulins control scleromyxoedema. Ann Rheum Dis 2002; 61: 59-61.
176. Doria A, Cutolo M, Ghirardello A, Zampieri S, Vescovi F, Sulli A, Giusti M, Piccoli A, Grella P
Gambari PF. Steroid hormones and disease activity during pregnancy in systemic lupus
eythematosus. Arthritis Rheum 2002; 47: 202-9.
177. Casonato A, Pontara E, Doria A, Bertomoro A, Cattini MG, Gambari PF, Girolami A. Lack of
multimer organization of von Willebrand factor in an acquired con Willebrand syndrome. Br J
Haematol 2002; 116: 899-904.
178. Ostuni P, Botsios C, Sfriso P, Bertagnin A, Cozzi F, Doria A, Todesco S. Prevalence and clinical
features of fibromyalgia in systemic lupus erythematosus, systemic sclerosis and Sjogren's
syndrome. Minerva Med 2002; 93(3):203-9.
179. Franceschini F, Cavazzana I, Generali D, Quinzanini M, Ghirardello A, Doria A, Cattaneo R. Anti-Ku
Antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients. J
Rheumatol 2002; 29: 1393-7.
180. Ghirardello A, Caponi L, Franceschini F, Zampieri S, Gambari PF, Doria A. Diagnostic tests for
antiribosomal P protein antibodies: a comparative evaluation of immunoblotting and ELISA assays.
J Autoimmunity 2002; 19: 71-77.
181. Brucato A, Franceschini F, Doria A, Cimaz R, Meroni P, Tincani A, Pisoni M, Faden D, Motta M,
Frassi M, Castellino G, Tombini V, Canesi B. Pathogenetic associations of maternal Anti-Ro/SSA
antibodies. Lupus 2002; 11: 650-650.
182. Brucato A, Doria A, Frassi M, Castellino G, Franceschini F, Faden D, Pisoni MP, Solerte L,
Muscarà M, Lojacono A, Motta M, Cavazzana I, Ghirardello A, Vescovi F, Tombini V, Cimaz R,
Gambari PF, Meroni PL, Canesi B, Tincani A. Pregnancy outcome in 100 women with autoimmune
diseases and anti-Ro/SSA antibodies: a prospective controlled study. Lupus 2002; 11: 716-721.
183. Zampieri S, Degen W, Ghirardello A, Doria A, van Venrooij WJ. Dephosphorylation of autoantigenic
ribosomal P proteins during FAS-L induced apoptosis; a possible trigger for the development of the
autoimmune response in SLE patients. Ann Rheum Dis 2001; 60: 72-76.
184. Brucato A, Frassi M, Franceschini F, Cimaz R, Faden R, Pisoni MP, Muscarà M, Vignati G,
Stramba-Badiale M, Catelli L, Lojacono A, Cavazzana I, Ghirardello A, Vescovi F, Gambari PF,
Doria A, Meroni PL, Tincani A.. Risk of congenital complete heart block in newborns of mothers
Page 14 - Curriculum vitae of
LAST_NAME, FIRST_NAME
Doria, Andtrea
185.
186.
187.
188.
189.
190.
191.
192.
193.
194.
195.
196.
197.
198.
199.
200.
with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis:. A prospective study of
100 women. Arthritis Rheum 2001; 44: 1832-35.
Ghirardello A, Doria A, Zampieri S, Gambari PF, Todesco S. Autoantibodies to ribosomal P proteins
in systemic lupus erythematosus. Isr Med Assoc J 2001; 3(11): 854-7.
Zampieri S, Ghirardello A, Doria A, Tonello M. Bendo R, Rossini K, Gambari PF. The use of Tween
20 in immunoblotting assays for the detection of autoantibodies in connective tissue diseases. J
Immunol Methods 2000; 239: 1-11.
Ghirardello A, Doria A, Zampieri S, Gerli R, Rapizzi E, Gambari PF. Anti ribosomal P protein
antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity
for SLE and association with the IgG anticardiolipin antibodies. Ann Rheum Dis 2000; 59: 975-981.
Anselmino M, Zaninotto G, Costantini M, Ostuni PA, Ianiello A, Boccù C, Doria A, Todesco S,
Ancona E. Esophageal motor function in primary Sjögren syndrome. Correlation with dysphagia
and xerostomia Dig Dis Sci 1997; 42: 113-8.
George J, Gilburg B, Levy Y, Afec A, Damianovitch M, Ghirardello A, Doria A, Todesco S,
Shoenfeld Y. "Autoantibody dominance" pattern following idiotypic manipulation of naive mice by
immunization with anti-U1RNP antibodies. Pathobiology 1997; 65: 204-209.
Doria A, Biasinutto C, Ghirardello A, Sartori E, Rondinone R, Piccoli A, Veller Fornasa C, Gambari
PF. Photosensitivity in systemic lupus erythematosus: laboratory testing of ARA/ACR definition.
Lupus 1996; 5: 263-268.
Ghirardello A, Doria A, Vesco P, Vaccaro E, Bernardi C, Fagiolo U, Gambari PF. Blotting pattern of
IgG Anti-(U1)RNP antibodies in mixed connective tissue disease. Rheumatol Int 1996; 16: 145150.
Fiocco U, Cozzi L, Rigon C, Chieco-Bianchi F, Baldovin M, Cassisi GA, Gallo C, Doria A, Favaro
MA, Piccoli A, De Candia A, Rubaltelli L, Todesco S. Arthroscopic synoviectomy in rheumatoid and
psoriatic knee joint synovitis: long-term outcome. Br J Rheumatol 1996; 35: 463-470.
Balestrieri G, Doria A, Galeazzi M, Meroni PL, Migliorini P, Tavoni A, Tincani A, Bombardieri S. III
European Conference on Systemic Lupus Erythematosus. Conference summary. Clin Exp
Rheumatol 1996; 14(S-16): S3-S16.
Vitali C, Doria A, Tincani A, Fabbri P, Balestrieri G, Galeazzi M, Meroni PL, Migliorini P, Neri R,
Bombardieri S. International survey on the management of patients with SLE. General data on the
partecipating centers and the results of a questionnaire regarding mucocutaneous involvement.
Clin Exp Rheumatol 1996; 14(S-16): S17-S22.
Tincani A, Brey R, Balestrieri G, Vitali C, Doria A, Galeazzi M, Meroni PL, Migliorini P, Neri R,
Tavoni A, Bombardieri S. International survey on the management of patients with SLE. The results
of a questionnaire regarding neuropsychiatric manifestations. Clin Exp Rheumatol 1996; 14(S-16):
S23-S30.
Doria A, Vitali C, Tincani A, Balestrieri G, Galeazzi M, Meroni PL, Migliorini P, Neri R, Tavoni A,
Bombardieri S. International survey on the management of patients with SLE. The results of a
questionnaire regarding renal involvement. Clin Exp Rheumatol 1996; 14(S-16): S23-S30.
Doria A, Ghirardello A, Boscaro M, Viero ML, Vaccaro E, Patrassi GM, Gambari PF. Fibrinolysis
and coagulation abnormalities in systemic lupus erythematosus. Relationship with Raynaud's
phenomenon, disease activity, inflammatory indices, anticardiolipin antibodies and corticosteroid
therapy. Rheumatol Int 1995; 14: 207-11.
Ghirardello A, Doria A, Ruffatti A, Rigoli A, Vesco P, Calligaro A, Gambari PF. Antiphospholipid
antibodies (aPL) in systemic lupus erythematosus (SLE). Are they specific tools for the diagnosis of
aPL syndrome in SLE? Ann Rheum Dis 1994; 53: 140-2.
Ghirardello A, Doria A, Gambari PF. Antiphospholipid antibodies (aPL) in systemic lupus
erythematosus (SLE). Are they specific tools for the diagnosis of aPL syndrome in SLE? (Author's
reply) Ann Rheum Dis 1994; 53: 619-620.
Doria A, Vesco P, Zulian F, Gambari PF. The 1982 ARA/ACR criteria for classification of systemic
lupus erythematosus in pediatric age Clin Exp Rheumatol 1994; 12: 689-90.
Page 15 - Curriculum vitae of
LAST_NAME, FIRST_NAME
Doria, Andtrea
201. Doria A, Piccoli A, Vesco P, Vaccaro E, Marson P, De Silvestro G, Ossi E, Gambari PF. Therapy of
lupus nephritis: a two-year prospective study. Ann Med Interne 1994; 145: 307-311.
202. Rosada M, Fiocco U, De Silvestro G, Doria A, Cozzi L, Favaretto M, Todesco S. Effect of DPenicillamine on T cell phenotype in scleroderma. Comparison between treated and untreared
patients. Clin Exp Rheumatol 1993; 11: 143-148.
203. Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, D'Ascanio A, Bombardieri S,
and the European Consensus Study Group for Disease Activity in SLE (Doria A et al.). Disease
activity in systemic lupus erythematosus: report of the Consensus Study Group of the European
Workshop for Rheumatology Research. I. A descriptive analysis of 704 european lupus patients.
Clin Exp Rheumatol 1992; 10: 527-39.
204. Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, Neri R, Bombardieri S, and
the European Consensus Study Group for Disease Activity in SLE (Doria A et al.). Disease activity
in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop
for Rheumatology Research. II. Identification of the variables indicative of disease activity and their
use in the development of an activity score. Clin Exp Rheumatol 1992; 10: 541-47.
205. Bencivelli W, Vitali C, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, Bombardieri S, and the
European Consensus Study Group for Disease Activity in SLE (Doria A et al.). Disease activity in
systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop
for Rheumatology Research. III. Development of a computerised clinical chart and its application to
the comparison of different indices of disease activity. Clin Exp Rheumatol 1992; 10: 549-54.
206. Ramonda R, Doria A, Villanova C, Vaccaro E, Punzi L, Fasoli G, Gambari PF. Evaluation de
l'atteinte cardique au cours du lupus erythemateux dissemine. etude clinique et
echocardiographique. Rev Rhum 1992; 59 (12): 790-796.
207. Doria A, Di Lenardo L, Vario S, Calligaro A, Vaccaro E, Gambari PF. Cyclosporin A in a pregnant
patient with systemic lupus erythematosus. Rheumatol Int 1992; 12: 77-8.
208. Doria A, Ruffatti A, Calligaro A, Del Ross T, Ghirardello A, Gambari PF. Antiphospholipid antibodies
in mixed connective tissue disease. Clin Rheumatol 1992; 11: 48-50.
209. Doria A. Ghirardello A, de Zambiasi P, Ruffatti A, Gambari PF.Japanese diagnostic criteria for
mixed connective tissue disease in Caucasian patients. J Rheumatol 1992; 19: 259-264.
210. Doria A, Bonavina L, Anselmino M, Ruffatti A, Favaretto A, Gambari PF, Peracchia A, Todesco S.
Esophageal involvment in Mixed Connective Tissue Disease. J Rheumatol 1991; 18: 685-90.
211. Ruffatti A, Calligaro A, Del Ross T, Targa L, Ghirardello A, Doria A, Todesco S. Clinical value of a
peculiar fluorescence nuclear staining in systemic sclerosis. Clin Exp Rheumatol 9: 29-34, 1991.
212. Ruffatti A, Calligaro A, Del Ross T, Bertoli MT, Doria A, Rossi L, Todesco S. Anti-double stranded
DNA antibodies in the healthy elderly prevalence and characteristics. J Clin Immunol 1990;10 (6):
300-303.
213. Ruffatti A, Artifoni L, Glorioso S, Calligaro A, Doria A, Gambari PF, Todesco S. Prevalence of
anticentromere antibody in blood relatives of anticentromere positive patients. J Rheumatol 1985;
12: 940-3.
Page 16 - Curriculum vitae of
LAST_NAME, FIRST_NAME
Doria, Andtrea